The macula allows us to see fine detail for activities such as reading, recognising faces, watching television and driving. It also helps us to see colour.
As we get older, the macula (the central part of the retina responsible for detailed vision) can begin to break down, causing blurred vision.
Age-related macular degeneration signs include the appearance of small yellow deposits called drusen, which form under the retina. These are accumulated waste products which, as they get larger, stop the flow of nutrients to the retina and cause the layer of supporting cells beneath it to become very thin.
When cells in this layer die, the overlying macula degenerates and loses its visual function.
Driving safely with the condition is one of many considerations for people who get age related macular degeneration.
There are two main types of AMD
Age-related macular degeneration (AMD) is classified into two types—dry (atrophic) and wet (neovascular or exudative)—because they represent distinct pathological processes affecting the retina.
The extent of the degeneration may be different in each eye and may not progress at the same rate.
Dry AMD
Dry AMD (atrophic macular degeneration) is the most common type of AMD, accounting for around 90% of all cases. The cells of the macula slowly break down, causing vision to become blurred.
Dry AMD generally affects both eyes, but vision can be affected more in one eye than the other and it affects central rather than peripheral vision.
Over time, sometimes many years, the disease process can worsen, with more of the macula being affected. This advanced form is called geographic atrophy.
Learn more about how Optegra can help with Dry AMD. Treatment of age-related macular degeneration will depend on whether it is the wet or dry type.
Wet AMD
Wet AMD (exudative macular degeneration) accounts for around 10% of all AMD cases. It is caused by the growth of abnormal blood vessels in the retina. These new blood vessels leak fluid into the retina and cause rapid onset of distorted vision and scarring at the back of the eye.
If left untreated this results in retinal tissue deterioration , leaving a central blind spot. Treatment can preserve but not restore vision at this stage. Treatments include anti-VEGF treatments at regular intervals usually between four to eight weeks until the macula is stable.
Most AMD patients start with the dry form with 10% of people developing the wet form. Although the wet type is less common it tends to be more aggressive, causing greater and more rapid visual loss.
You can learn more about wet vs dry macular degeneration on our blog.